Loading
Every dated change on the records linked to Acute promyelocytic leukaemia, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
All-trans retinoic acid plus arsenic trioxide was superior to retinoic acid plus chemotherapy for event-free and overall survival in non-high-risk APL.
A milestone in how this cancer is treated.